2022.08.03 14:55

Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit

Roche Holdings AG's RHHBY 1H FY22 sales reached CHF 32.3 billion, +5% Y/Y on higher sales of diagnostic tests and pharmaceuticals.Core operating profit increased 9% to CHF 12.

The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: